[The heparin tolerance test in the treatment of regional and diffuse atherosclerotic vascular diseases].
D000328:Adult; D000368:Aged; D001158:Arteries; D001161:Arteriosclerosis / Q000188:drug therapy / Q000201:enzymology*; D001162:Arteriosclerosis Obliterans / Q000188:drug therapy; D003327:Coronary Disease / Q000188:drug therapy; D005260:Female; D006493:Heparin; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D002537:Intracranial Arteriosclerosis / Q000188:drug therapy; D008071:Lipoprotein Lipase / Q000032:analysis*; D008297:Male; D008875:Middle Aged; D010417:Pentaerythritol Tetranitrate / Q000627:therapeutic use*; D014020:Tissue Extracts / Q000627:therapeutic use*; D015016:Yohimbine / Q000627:therapeutic use*
D014020:Tissue Extracts; D010417:Pentaerythritol Tetranitrate; D015016:Yohimbine; D006493:Heparin; D008071:Lipoprotein Lipase
Il test di tolleranza eparinica nel trattamento delle vasculopatie aterosclerotiche distrettuali e diffuse.